FDA Inspection 945583 — Mezzion Pharma Co., Ltd

Mezzion Pharma Co., Ltd — FEI 3011630595

The FDA completed an inspection of Mezzion Pharma Co., Ltd on Sep 11, 2015 in New Providence, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 11, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Providence, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.